[Therapy of viral hepatitis]

[Therapy of viral hepatitis] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Therapy of viral hepatitis] Abstract Text:

B Burckhardt,J Reichen,

Chronic viral hepatitis is a leading cause of chronic hepatitis, liver cirrhosis, hepatic decompensation and hepatocellular carcinoma worldwide. Here, we will briefly review common indications and current therapies for chronic hepatitis B and C and discuss practical aspects of these therapies. Current therapies for hepatitis C aim at viral eradication. With the introduction of pegylated interferon and ribavirin viral eradication is successful in about 55% of treated patients. The goal of therapy of HBe antigen positive chronic hepatitis B is seroconversion to anti-HBe which can be achieved with interferon alpha in 25-45% of patients. A loss of HBs can be achieved in approximately 10%. Responders proceed significantly less to cirrhosis or hepatocellular carcinoma. Anti-HBe positive patients can be treated with interferon alpha or lamivudine. The former requires longer treatment and the results are disappointing. Lamivudine is a promising agent in the treatment of chronic hepatitis B, but the success is hampered by a high relapse rate and the emergence of viral resistance.

[Therapy of viral hepatitis] Publishing Authors By Initials

B Burckhardt,J Reichen,

For similar investigative techniques: clinical laboratory techniques: microbiological techniques: viral load research abstracts see: investigative techniques: clinical laboratory techniques: microbiological techniques: viral load research

PUBMED ID PMID:

MEDLINE DATE:

[Therapy of viral hepatitis] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Therapeutische Umschau. Revue thérapeutique

VOLUME: 60

Page Numbers: 651-6

Journal Abbreviation:

ISSN: 0040-5930

DAY: 12

MONTH: Oct

YEAR: 2003

[Therapy of viral hepatitis] Information

Number of References:

LANGUAGE: ger

NlmUniqueID: 407224

[Therapy of viral hepatitis] Keywords Mesh Terms:

KEYWORDS: Viral Load

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: [Therapy of viral hepatitis] Information

Substance Name: Interferon Alfa-2b

Registry Number: 99210-65-8

Grant and Affiliation Information for [Therapy of viral hepatitis]

AFFILIATION: Institut für Klinische Pharmakologie, Universität Bern. beat.burckhardt@ikp.unibe.ch

Country: Switzerland

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Ther Umsch

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Therapy of viral hepatitis Related Publications

• Review: Ursodeoxycholic acid does not reduce risk for mortality or liver transplantation in primary biliary cirrhosis.
• [Are diuretics in the treatment of portal hypertension rational?]
• [Clinical features of anemia simulating eclampsia.]
• [Drug treatment of cholestatic liver diseases]
• [Efficacy of Wintz's single roentgen irradiation in the control of carcinoma of the female genitalia.]
• [Gallstones--natural history and conservative management]
• [Management of the complications of portal hypertension]
• [Pathophysiology of cholestasis]
• [Post-traumatic arthrosis of the ankle joint following calcaneal fractures]
• [Prolonged peridural anesthesia in obstetrics; technique and results in Frauenspital, Basel.]
• [Rational diuretic therapy in patients with liver cirrhosis]
• [Surgical and conservative treatment of liver diseases]
• [Surgical therapy of cervical cancer and 5-year therapy in general.]
• [Surgical therapy of genital carcinoma in women.]
• [The crush syndrome in obstetrics.]
• [Therapy of viral hepatitis]